Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and major adverse events of endobronchial ultrasound performed under conscious sedation: Insights from 3,454 procedures over 14 years and a systematic review of literature.

Lung India : official organ of Indian Chest Society·2026
Same author

Efficacy and safety of daily drug regimens containing high-dose versus standard-dose rifampicin for treating pulmonary tuberculosis: Systematic review and meta-analysis.

Lung India : official organ of Indian Chest Society·2026
Same author

Ultrasound-Guided Superficial Versus Deep Continuous Serratus Anterior Plane Block in Patients Undergoing Thoracotomy for Lung Surgery: A Randomized Controlled Trial.

Annals of cardiac anaesthesia·2026
Same author

A proof of concept study on the diagnostic utility of in vivo expressed mycobacterial transcripts in tuberculous pleuritis.

Scientific reports·2026
Same author

Primary Fontan operation in adults: Challenges and early outcomes in adults at a tertiary cardiac centre in India.

Asian cardiovascular & thoracic annals·2026
Same author

Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial.

The Lancet. Respiratory medicine·2026

Related Experiment Video

Updated: Aug 28, 2025

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

69.0K

How We Do It: Whole Lung Lavage.

Deepa Shrestha1, Sahajal Dhooria2, Ganesh Kumar Munirathinam1

  • 1department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|September 19, 2022
PubMed
Summary

Pulmonary alveolar proteinosis (PAP) is treated with whole lung lavage (WLL) to clear surfactant buildup. This guide details the WLL procedure, aiming for clearer lavage fluid and improved respiratory function in PAP patients.

Keywords:
Pulmonary alveolar proteinosisbronchoalveolar lavagebronchoscopyinterstitial lung disease: diffuse parenchymal lung disease

More Related Videos

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

73.9K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K

Related Experiment Videos

Last Updated: Aug 28, 2025

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

69.0K
Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield
11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

73.9K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K

Area of Science:

  • Pulmonology
  • Critical Care Medicine

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare lung disease causing surfactant accumulation and hypoxemic respiratory failure.
  • Whole lung lavage (WLL) is the primary treatment, physically removing lipoproteinaceous material from alveoli.
  • Despite its use since 1963, WLL lacks standardized protocols.

Purpose of the Study:

  • To provide a detailed, step-by-step description of the Whole Lung Lavage (WLL) procedure for Pulmonary Alveolar Proteinosis (PAP).
  • To outline essential precautions and monitoring strategies during WLL.
  • To offer visual aids, including videos, demonstrating key aspects of the procedure.

Main Methods:

  • WLL performed under general anesthesia with a double lumen endotracheal tube for one-lung ventilation.
  • Lavage of one lung using liter aliquots of pre-warmed saline.
  • Gravity-assisted drainage after each cycle until lavage fluid clears (typically 15-20 cycles).

Main Results:

  • Successful physical removal of surfactant and lipoproteinaceous material from the alveolar spaces.
  • Demonstration of effective one-lung ventilation and lung isolation techniques.
  • Clearance of lavage fluid indicating procedure completion.

Conclusions:

  • The described WLL procedure provides a standardized approach to managing PAP.
  • Careful execution and monitoring are crucial for patient safety and treatment efficacy.
  • This detailed guide and accompanying videos can aid clinicians in performing WLL.